OpportunityTitle: Prevention Innovation Program III (PIP) (R01)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Description: The Prevention Innovation Program III (PIP) encourages research applications in Non-vaccine Biomedical Prevention (nBP) research. The PIP is intended to support high-risk/innovative research and development efforts to establish and maintain a sustainable pipeline for the prevention of HIV acquisition/transmission. The PIP will support: 1) discovery and development of novel and under-explored nBP candidates/strategies, 2) discovery and development of nBP drug delivery systems (DDS), 3) studies of the impact of nBP prevention products and DDS on genital and gastrointestinal (GI) mucosa function, 4) development of emerging technologies to support and facilitate nBP prevention product and DDS discovery and development, 5) development of age appropriate formulation strategies (AFS), and 6) development of Multipurpose Prevention Technologies (MPT) for prevention of HIV acquisition/transmission.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster&lt;br/&gt;FBOWebmaster@OD.NIH.GOV&lt;br/&gt;